NASDAQ: VXRTVaxart Inc Stock Ownership - Who owns Vaxart?
Insider buying vs selling
Have Vaxart Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| W. Mark Watson | Director | 2024-06-18 | 20,000 | $0.68 | $13.58kBuy |
| Phillip E. Lee | Chief Financial Officer | 2024-06-12 | 2,007 | $0.76 | $1.53kSell |
| James F. Cummings | Chief Medical Officer | 2024-03-28 | 3,292 | $1.30 | $4.28kSell |
| Sean Tucker | SVP Chief Scientific Officer | 2024-03-28 | 3,902 | $1.30 | $5.07kSell |
| Edward B. Berg | SVP General Counsel | 2024-02-02 | 9,220 | $1.20 | $11.06kSell |
| Sean Tucker | SVP Chief Scientific Officer | 2024-02-02 | 9,220 | $1.20 | $11.06kSell |
| James F. Cummings | Chief Medical Officer | 2024-02-02 | 7,965 | $1.20 | $9.56kSell |
| Phillip E. Lee | Chief Financial Officer | 2023-12-15 | 5,943 | $0.63 | $3.74kSell |
VXRT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VXRT insiders and whales buy or sell their stock.
VXRT Shareholders
What type of owners hold Vaxart Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Richard J. Markham | 13.54% | 30,793,670 | $19.25M | Insider |
| Care Capital III LLC | 13.54% | 30,793,670 | $19.25M | Insider |
| Jan Leschly | 13.54% | 30,793,670 | $19.25M | Insider |
| Sio Capital Management LLC | 5.98% | 13,608,244 | $8.51M | Institution |
| Vanguard Group Inc | 4.43% | 10,077,418 | $6.30M | Institution |
| Armistice Capital LLC | 3.82% | 8,691,046 | $5.43M | Insider |
| David M. Knott | 3.03% | 6,903,806 | $4.31M | Insider |
| Third Point LLC | 3.03% | 6,890,000 | $4.31M | Insider |
| Millennium Management LLC | 1.74% | 3,969,091 | $2.48M | Institution |
| Geode Capital Management LLC | 1.12% | 2,543,228 | $1.59M | Institution |
VXRT vs Biotech Stocks
Vaxart Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.